New hope in the horizon: Cancer stern cells. Acta Biochim Biophys Sin (Shanghai). 2010 Apr;42(4):237-42.
Potential stern cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In vivo. 2008 Jan-Feb;22(1):89-92.
Tumor stem cells and drug resistance. Nat Rev Cancer 2005 Apr;5(4):275-84.
Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis. J Clin Pharmacol. 2005 Aug;45(8):872-7
Cancer stem cells in solid tumors. Semin Cancer Biol. 2010 Apr;20(2):77-84.
Normal and neoplastic stem cells. Novartis Found Symp. 2005;265:35-50.
Farrar. Cancer Stem Cells. Cambridge University Press. http://www.cambridge.orglgb/knowledge/isbnl.
Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Res 2006 Oct;66(19):9339-44.
Increased expression of stem cell markers in malignant melanoma. Modem Pathology 2007;20:102-107.
Identification of Cancer stem cell-Like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res April 2007;67(8):3716-24.
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006 Apr; 38(4):431-40.
A subpopulation of CD 133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. 2010 Mar 28;289(2): 151-60.
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008 Jul; 14(13):4085-95.
